Boosting Neurogenesis in the Adult Hippocampus Using Antidepressants and Mesenchymal Stem Cells

The hippocampus is one of the few privileged regions (neural stem cell niche) of the brain, where neural stem cells differentiate into new neurons throughout adulthood. However, dysregulation of hippocampal neurogenesis with aging, injury, depression and neurodegenerative disease leads to debilitati...

Full description

Bibliographic Details
Main Authors: Marta Kot, Pawan Kumar Neglur, Anna Pietraszewska, Leonora Buzanska
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/11/20/3234
_version_ 1797474396358574080
author Marta Kot
Pawan Kumar Neglur
Anna Pietraszewska
Leonora Buzanska
author_facet Marta Kot
Pawan Kumar Neglur
Anna Pietraszewska
Leonora Buzanska
author_sort Marta Kot
collection DOAJ
description The hippocampus is one of the few privileged regions (neural stem cell niche) of the brain, where neural stem cells differentiate into new neurons throughout adulthood. However, dysregulation of hippocampal neurogenesis with aging, injury, depression and neurodegenerative disease leads to debilitating cognitive impacts. These debilitating symptoms deteriorate the quality of life in the afflicted individuals. Impaired hippocampal neurogenesis is especially difficult to rescue with increasing age and neurodegeneration. However, the potential to boost endogenous Wnt signaling by influencing pathway modulators such as receptors, agonists, and antagonists through drug and cell therapy-based interventions offers hope. Restoration and augmentation of hampered Wnt signaling to facilitate increased hippocampal neurogenesis would serve as an endogenous repair mechanism and contribute to hippocampal structural and functional plasticity. This review focuses on the possible interaction between neurogenesis and Wnt signaling under the control of antidepressants and mesenchymal stem cells (MSCs) to overcome debilitating symptoms caused by age, diseases, or environmental factors such as stress. It will also address some current limitations hindering the direct extrapolation of research from animal models to human application, and the technical challenges associated with the MSCs and their cellular products as potential therapeutic solutions.
first_indexed 2024-03-09T20:29:27Z
format Article
id doaj.art-bcd6a0d316174ce798d544e035385147
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T20:29:27Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-bcd6a0d316174ce798d544e0353851472023-11-23T23:27:44ZengMDPI AGCells2073-44092022-10-011120323410.3390/cells11203234Boosting Neurogenesis in the Adult Hippocampus Using Antidepressants and Mesenchymal Stem CellsMarta Kot0Pawan Kumar Neglur1Anna Pietraszewska2Leonora Buzanska3Department of Stem Cell Bioengineering, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawinskiego 5 Street, 02-106 Warsaw, PolandDepartment of Stem Cell Bioengineering, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawinskiego 5 Street, 02-106 Warsaw, PolandDepartment of Stem Cell Bioengineering, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawinskiego 5 Street, 02-106 Warsaw, PolandDepartment of Stem Cell Bioengineering, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawinskiego 5 Street, 02-106 Warsaw, PolandThe hippocampus is one of the few privileged regions (neural stem cell niche) of the brain, where neural stem cells differentiate into new neurons throughout adulthood. However, dysregulation of hippocampal neurogenesis with aging, injury, depression and neurodegenerative disease leads to debilitating cognitive impacts. These debilitating symptoms deteriorate the quality of life in the afflicted individuals. Impaired hippocampal neurogenesis is especially difficult to rescue with increasing age and neurodegeneration. However, the potential to boost endogenous Wnt signaling by influencing pathway modulators such as receptors, agonists, and antagonists through drug and cell therapy-based interventions offers hope. Restoration and augmentation of hampered Wnt signaling to facilitate increased hippocampal neurogenesis would serve as an endogenous repair mechanism and contribute to hippocampal structural and functional plasticity. This review focuses on the possible interaction between neurogenesis and Wnt signaling under the control of antidepressants and mesenchymal stem cells (MSCs) to overcome debilitating symptoms caused by age, diseases, or environmental factors such as stress. It will also address some current limitations hindering the direct extrapolation of research from animal models to human application, and the technical challenges associated with the MSCs and their cellular products as potential therapeutic solutions.https://www.mdpi.com/2073-4409/11/20/3234adult hippocampal neurogenesisneurogenesisneurodegenerationhippocampusWnt signalingantidepressants
spellingShingle Marta Kot
Pawan Kumar Neglur
Anna Pietraszewska
Leonora Buzanska
Boosting Neurogenesis in the Adult Hippocampus Using Antidepressants and Mesenchymal Stem Cells
Cells
adult hippocampal neurogenesis
neurogenesis
neurodegeneration
hippocampus
Wnt signaling
antidepressants
title Boosting Neurogenesis in the Adult Hippocampus Using Antidepressants and Mesenchymal Stem Cells
title_full Boosting Neurogenesis in the Adult Hippocampus Using Antidepressants and Mesenchymal Stem Cells
title_fullStr Boosting Neurogenesis in the Adult Hippocampus Using Antidepressants and Mesenchymal Stem Cells
title_full_unstemmed Boosting Neurogenesis in the Adult Hippocampus Using Antidepressants and Mesenchymal Stem Cells
title_short Boosting Neurogenesis in the Adult Hippocampus Using Antidepressants and Mesenchymal Stem Cells
title_sort boosting neurogenesis in the adult hippocampus using antidepressants and mesenchymal stem cells
topic adult hippocampal neurogenesis
neurogenesis
neurodegeneration
hippocampus
Wnt signaling
antidepressants
url https://www.mdpi.com/2073-4409/11/20/3234
work_keys_str_mv AT martakot boostingneurogenesisintheadulthippocampususingantidepressantsandmesenchymalstemcells
AT pawankumarneglur boostingneurogenesisintheadulthippocampususingantidepressantsandmesenchymalstemcells
AT annapietraszewska boostingneurogenesisintheadulthippocampususingantidepressantsandmesenchymalstemcells
AT leonorabuzanska boostingneurogenesisintheadulthippocampususingantidepressantsandmesenchymalstemcells